Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth
Choh Yeung(National Institutes of Health), Lee J. Helman(American Osteopathic Association), Javed Khan(Kent State University), Louis M. Staudt(National Cancer Institute), Patrick J. Grohar(National Institutes of Health), Xiaolin Wan(National Cancer Institute), Vu N. Ngo(City of Hope), Fernanda I. Arnaldez(MacroGenics (United States)), Stephen M. Hewitt(National Institutes of Health), C. Khanna(National Cancer Institute), A Asante(National Cancer Institute)
Cited by 44
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k